Abstract
Melanoma remains the most lethal form of skin cancer, necessitating early detection for optimal patient outcomes. This study presents an advanced automated diagnostic system utilizing state-of-the-art convolutional neural networks—NFNet-L0, ResNeSt-101e, and MogaNet-XT—to classify nine types of cutaneous lesions from dermoscopic images. Leveraging a diverse dataset of 22,618 images from the International Skin Imaging Collaboration (ISIC) and Venezuelan clinical centers, the system demonstrates 96.2% accuracy in multi-class classification, outperforming conventional methods. Robust data augmentation and class-balancing strategies ensured balanced performance across all lesion categories. Clinical validation by five board-certified Venezuelan dermatologists confirmed the system’s diagnostic accuracy, clinical relevance, and usability. The application’s deployment as an accessible web interface highlights its potential for supporting dermatological diagnosis, particularly in resource-limited settings. Our findings underscore the promise of deep learning-driven tools for enhancing skin cancer detection and improving healthcare equity in Latin America and beyond.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research received no external funding. All computational work was conducted using the author's personal resources.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The El Avila Clinic Research and Ethics Committee, Caracas, Venezuela, approved the use of fully anonymized dermoscopic images and clinical survey data for research purposes as described in the manuscript. All data were de-identified prior to analysis, and patient consent was obtained for research use in accordance with institutional guidelines. No formal IRB protocol number is issued in this institution.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
The ISIC dermoscopic image dataset used in this study is publicly available at https://www.isic-archive.com. Clinical images from El Avila Clinic, Caracas, Venezuela, are not publicly available due to patient privacy and institutional data sharing restrictions but may be available from the corresponding author upon reasonable request and with appropriate ethical approval.
